Binder Information
| Binder General Information | Top | |||
|---|---|---|---|---|
| Binder ID |
BA0KZ4
|
|||
| Binder Name |
Cephapirin sodium
|
|||
| Synonyms |
cefapirin sodium; Sodium cefapirin; Sodium cephapirin; Cefadyl; UNII-431LFF7I7J; Cefatrexyl; Ambrocef; Cefatrex; Cefapirin sodium salt; BLP 1322; Sodium 7-(pyrid-4-ylthioacetamido)cephalosporanate; Cephapirin sodium salt; 431LFF7I7J; BL-P 1322; Cefaloject; Cephatrexil; Cefa lak; Cela-Lak/ToDay; 7-(alpha-(4-Pyridylthio)acetamido)cephalosporanic acid sodium salt; DSSTox_CID_25574; DSSTox_RID_80971; DSSTox_GSID_45574; Brisfirina; Cephatrexyl; Brisporin; Bristocef; Cefapirina sodica; Cefadyl IM/IV; Cefa-Lak (Veterinary); Antibiotic BL-P 1322; 356C603; Cephapirin sodium [USAN:USP]; Prestwick_27; NCGC00017093-01; Cefadyl (TN); EINECS 246-194-2; NSC 179171; Cefapirin sodium (JAN); Cephapirin sodium (USP); Cephapirin sodium, >=96%; SCHEMBL64430; SPECTRUM1500167; CHEMBL1201043; DTXSID7045574; HMS500C04; HMS1570L03; HMS1920K13; HMS2091A16; Tox21_110772; BL-P-1322; CCG-38912; Cefapirin sodium, analytical standard; AKOS024282660; Tox21_110772_1; NCGC00093735-01; NCGC00162116-04; ST057376; EU-0100279; C 8270; C08101; D00908; Q27106128; Cefapirin sodium, European Pharmacopoeia (EP) Reference Standard; Cephapirin sodium, United States Pharmacopeia (USP) Reference Standard
Click to Show/Hide
|
|||
| Binder Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C17H16N3NaO6S2
|
|||
| Canonical SMILES |
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)[O-].[Na+]
|
|||
| InChI |
1S/C17H17N3O6S2.Na/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11;/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25);/q;+1/p-1/t13-,16-;/m1./s1
|
|||
| InChIKey |
VGEOUKPOQQEQSX-OALZAMAHSA-M
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:3545
|
|||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.